INTERNATIONAL PATENT: MORPHIC THERAPEUTIC, INC. FILES APPLICATION FOR "INHIBITING HUMAN INTEGRIN Α5Β1"

GENEVA, April 2 -- MORPHIC THERAPEUTIC, INC. (35 Gatehouse Drive, A2Waltham, Massachusetts 02451) filed a patent application (PCT/US2024/047672) for "INHIBITING HUMAN INTEGRIN Alpha5Beta1" on Sep 20, 2024. With publication no. WO/2025/064802, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOWLING, James E. (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusetts 02451), BABAOGLU, Kerim (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusetts 02451), BUCKMELTER, Alex (c/o Morphic Therap...